BCL2 and cancer: Taken together the underlying mechanisms for the observed markedly promoted growth inhibition and apoptosis induction by combined therapy can be the concomitant suppression of CDK1, CDK9, c-FIP, Mcl-1 and Bcl-2 and upregulation of Bax in cancer cells (Figure 8).